Director Cedars-Sinai Cancer Center Cedars-Sinai Medical Center Los Angeles, California, United States
Description: This presentation will explore a cutting-edge multi-omic analytic platform that uses advanced molecular profiling and machine learning to predict disease-specific survival in pancreatic cancer. Discover how our Molecular Twin platform, validated with external data, can revolutionize clinical care and scientific discovery across cancer types.
Learning Objectives: 1. Understand the advantages of muti-omic profiling of tumor and host in biomarker development. 2. Understand the use and utility of artificial intelligence in biomarker development. 3. Learn how the development of parsimonious biomarker panels can democratize precision oncology globally.
